Labeled for this condition
Medicines for glaucoma
20 medicines have an FDA label indicated for glaucoma; 16 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for glaucoma?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Timolol | Timoptic, Betimol, Timoptic-Xe | 22 labelers | $0.774 per mL 0.5% eye drops | No | No current entry | 20 |
| Mitomycin | Zusduri, Jelmyto, Mitosol | 11 labelers | n/a | Yes | No current entry | 2 |
| Brimonidine | Lumify, Alphagan, Mirvaso | 14 labelers | $9.06 per mL 0.1% drop | No | No current entry | 4 |
| Bimatoprost | Lumigan, Durysta, Zolymbus | 13 labelers | $6.97 per mL 0.03% eye drops | No | No current entry | 5 |
| Pilocarpine | Salagen, Qlosi | 7 labelers | $0.338 per tablet 5 mg tablet | No | A presentation being discontinued | 4 |
| Dorzolamide and timolol | Cosopt | 14 labelers | $0.893 per mL Dorzolamide-timolol eye drops | No | No current entry | 1 |
| Brimonidine and timolol | Combigan | 14 labelers | $2.15 per mL 0.2%-0.5% | No | No current entry | 5 |
| Latanoprost | Xalatan, Iyuzeh, Xelpros | 14 labelers | $1.58 per mL 0.005% eye drops | No | No current entry | 3 |
| Travoprost | Travatan, Idose | 11 labelers | $9.07 per mL 0.004% eye drop | No | A presentation being discontinued | 3 |
| Dorzolamide | none listed | 14 labelers | $0.835 per mL 2% eye drops | No | No current entry | 0 |
| Betaxolol | Betoptic | 3 labelers | $0.591 per tablet 10 mg tablet | No | No current entry | 3 |
| Brinzolamide | Azopt | 4 labelers | $9.00 per mL 1% eye drops | No | No current entry | 1 |
| Tafluprost | Zioptan | 3 labelers | $2.45 per unit 0.0015% eye drop | No | No current entry | 0 |
| Latanoprostene bunod | Vyzulta | 1 labeler | $102.27 per mL 0.024% eye solution | No | No current entry | 0 |
| Brimonidine and brinzolamide | Simbrinza | none listed | $26.04 per mL 1%-0.2% eye drop | No | No current entry | 0 |
| Carteolol | none listed | 1 labeler | $1.63 per mL 1% eye drops | No | No current entry | 0 |
| Latanoprost and netarsudil | Rocklatan | none listed | $139.40 per mL 0.02%-0.005% eye drp | No | No current entry | 0 |
| Levobunolol | none listed | 1 labeler | $2.82 per mL 0.5% eye drops | No | No current entry | 0 |
| Netarsudil | Rhopressa | none listed | $131.68 per mL 0.02% eye solution | No | No current entry | 0 |
| Omidenepag isopropyl | Omlonti | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price